Catalyst Biosciences (CBIO) Short Interest Ratio & Short Volume

Short interest is the volume of Catalyst Biosciences shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 34,100 shares of CBIO short. Learn More on Catalyst Biosciences' current short interest.

Catalyst Biosciences saw a drop in short interest in October. As of October 15th, there was short interest totaling 34,100 shares, a drop of 52.6% from the previous total of 71,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Catalyst Biosciences: XOMA Co. (2.36%), Verastem, Inc. (3.10%), Vanda Pharmaceuticals Inc. (4.57%), Rigel Pharmaceuticals, Inc. (2.86%), Regulus Therapeutics Inc. (9.44%), Lexicon Pharmaceuticals, Inc. (8.90%), Emergent BioSolutions Inc. (11.38%), Aclaris Therapeutics, Inc. (6.89%), Equillium, Inc. (6.27%), AcelRx Pharmaceuticals, Inc. (3.16%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks.

Short selling CBIO is an investing strategy that aims to generate trading profit from Catalyst Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Catalyst Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CBIO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBIO, twice per month. The most recent reporting period available is October, 15 2023.